112 related articles for article (PubMed ID: 3456492)
21. Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition.
Patey G; De La Baume S; Schwartz JC; Gros C; Roques B; Fournie-Zaluski MC; Soroca-Lucas E
Science; 1981 Jun; 212(4499):1153-5. PubMed ID: 7015510
[TBL] [Abstract][Full Text] [Related]
22. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP
Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
[TBL] [Abstract][Full Text] [Related]
23. Neurokinin B is hydrolysed by synaptic membranes and by endopeptidase-24.11 (enkephalinase) but not by angiotensin converting enzyme.
Hooper NM; Turner AJ
FEBS Lett; 1985 Oct; 190(1):133-6. PubMed ID: 2995126
[TBL] [Abstract][Full Text] [Related]
24. Enzyme-resistant CCK analogs with high affinities for central receptors.
Charpentier B; Durieux C; Pelaprat D; Dor A; Reibaud M; Blanchard JC; Roques BP
Peptides; 1988; 9(4):835-41. PubMed ID: 3226959
[TBL] [Abstract][Full Text] [Related]
25. Enkephalinase is involved in the degradation of endogenous substance P released from slices of rat substantia nigra.
Mauborgne A; Bourgoin S; Benoliel JJ; Hirsch M; Berthier JL; Hamon M; Cesselin F
J Pharmacol Exp Ther; 1987 Nov; 243(2):674-80. PubMed ID: 2445957
[TBL] [Abstract][Full Text] [Related]
26. Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan.
Roques BP; Lucas-Soroca E; Chaillet P; Costentin J; Fournié-Zaluski MC
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3178-82. PubMed ID: 6304695
[TBL] [Abstract][Full Text] [Related]
27. Degradation of neurotensin by rat brain synaptic membranes: involvement of a thermolysin-like metalloendopeptidase (enkephalinase), angiotensin-converting enzyme, and other unidentified peptidases.
Checler F; Vincent JP; Kitabgi P
J Neurochem; 1983 Aug; 41(2):375-84. PubMed ID: 6308159
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological activity of Boc [Nle28, Nle31]CCK27-33, a highly potent CCK8 analogue.
Ruiz-Gayo M; Daugé V; Menant I; Bégué D; Gacel G; Roques BP
Peptides; 1985; 6(3):415-20. PubMed ID: 2415950
[TBL] [Abstract][Full Text] [Related]
29. Hydrolysis of the C-terminal octapeptide of cholecystokinin by rat kidney membranes: characterization of the cleavage by solubilized endopeptidase-24.11.
Najdovski T; Collette N; Deschodt-Lanckman M
Life Sci; 1985 Sep; 37(9):827-34. PubMed ID: 3897758
[TBL] [Abstract][Full Text] [Related]
30. The endogenous tripeptide Tyr-Gly-Gly as a possible metabolite of opioid peptides in rat brain: identification, regional distribution, effects of lesions and formation in depolarized slices.
Giros B; Llorens-Cortes C; Gros C; Schwartz JC
Peptides; 1986; 7(4):669-77. PubMed ID: 3532054
[TBL] [Abstract][Full Text] [Related]
31. Cholecystokinin octapeptide analogues stable to brain proteolysis.
Knight M; Barone P; Tamminga CA; Steardo L; Chase TN
Peptides; 1985; 6(4):631-4. PubMed ID: 2999729
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of substance P degradation in rat brain preparations by peptide hydroxamic acids.
Laufer R; Ewenson A; Gilon C; Chorev M; Selinger Z
Eur J Biochem; 1985 Jul; 150(1):135-40. PubMed ID: 2410267
[TBL] [Abstract][Full Text] [Related]
33. Study of endogenous Tyr-Gly-Gly, a putative enkephalin metabolite, in mouse brain: validation of a radioimmunoassay, localisation and effects of peptidase inhibitors.
Llorens-Cortes C; Gros C; Schwartz JC
Eur J Pharmacol; 1985 Dec; 119(3):183-91. PubMed ID: 3912194
[TBL] [Abstract][Full Text] [Related]
34. [3H] Boc [Nle28, 31]CCK27-33, a new highly labelled ligand for CCK receptors: binding on brain and on pancreas.
Pélaprat D; Zajac JM; Gacel G; Durieux C; Morgat JL; Sasaki A; Roques BP
Life Sci; 1985 Dec; 37(26):2483-90. PubMed ID: 3001463
[TBL] [Abstract][Full Text] [Related]
35. Effects of kelatorphan and other peptidase inhibitors on the in vitro and in vivo release of methionine-enkephalin-like material from the rat spinal cord.
Bourgoin S; Le Bars D; Artaud F; Clot AM; Bouboutou R; Fournie-Zaluski MC; Roques BP; Hamon M; Cesselin F
J Pharmacol Exp Ther; 1986 Jul; 238(1):360-6. PubMed ID: 3459871
[TBL] [Abstract][Full Text] [Related]
36. Similar potencies of CCK-8 and its analogue BOC(Nle28;Nle31)CCK27-33 on the self-stimulation behaviour both are antagonized by a newly synthesized cyclic CCK analogue.
Heidbreder C; Roques BP; De Witte P
Neuropeptides; 1989; 13(2):89-94. PubMed ID: 2739884
[TBL] [Abstract][Full Text] [Related]
37. Enkephalin degradation by enkephalinergic neuroblastoma cells. Involvement of angiotensin-converting-enzyme.
Palenker J; Lentzen H; Brandt U
Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):214-7. PubMed ID: 6328331
[TBL] [Abstract][Full Text] [Related]
38. Purification and characterization of enkephalin-degradating enzymes from calf-brain striatum.
van Amsterdam JG; van Buuren KJ; Soudijn W
Biochem Biophys Res Commun; 1983 Sep; 115(2):632-41. PubMed ID: 6578795
[TBL] [Abstract][Full Text] [Related]
39. Relationship between enkephalinase inhibition of thiorphan in vivo and its analgesic activity.
Hachisu M; Takahashi H; Hiranuma T; Shibazaki Y; Murata S
J Pharmacobiodyn; 1985 Sep; 8(9):701-10. PubMed ID: 3910797
[TBL] [Abstract][Full Text] [Related]
40. Solid phase synthesis of a fully active analogue of cholecystokinin using the acid-stable Boc-Phe (p-CH2) SO3H as a substitute for Boc-Tyr(SO3H) in CCK8.
Gonzalez-Muniz R; Cornille F; Bergeron F; Ficheux D; Pothier J; Durieux C; Roques BP
Int J Pept Protein Res; 1991 Apr; 37(4):331-40. PubMed ID: 1894448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]